- FMTX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Forma Therapeutics (FMTX) 8-K16 Dec 21First Phase 2 combination trial results presented in oral session at 2021 ASH Annual MeetingFinancial data
Company Profile